GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HeXun Biosciences Co Ltd (ROCO:6986) » Definitions » Dividends per Share

HeXun Biosciences Co (ROCO:6986) Dividends per Share : NT$0.00 (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is HeXun Biosciences Co Dividends per Share?

HeXun Biosciences Co's dividends per share for the six months ended in Dec. 2024 was NT$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.00. Its Dividend Payout Ratio for the six months ended in Dec. 2024 was 0.00. As of today, HeXun Biosciences Co's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


HeXun Biosciences Co Dividends per Share Historical Data

The historical data trend for HeXun Biosciences Co's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeXun Biosciences Co Dividends per Share Chart

HeXun Biosciences Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Dividends per Share
- - - - -

HeXun Biosciences Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Dividends per Share Get a 7-Day Free Trial - - - - -

Competitive Comparison of HeXun Biosciences Co's Dividends per Share

For the Biotechnology subindustry, HeXun Biosciences Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeXun Biosciences Co's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HeXun Biosciences Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where HeXun Biosciences Co's Dividend Yield % falls into.


;
;

HeXun Biosciences Co Dividends per Share Calculation

Dividends paid to per common share.


HeXun Biosciences Co  (ROCO:6986) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

HeXun Biosciences Co's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2024 )/ EPS without NRI (Q: Dec. 2024 )
=0/ 1.52
=0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HeXun Biosciences Co Dividends per Share Related Terms

Thank you for viewing the detailed overview of HeXun Biosciences Co's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


HeXun Biosciences Co Business Description

Traded in Other Exchanges
N/A
Address
Chunri Road, 6 F., No. 1490, Taoyuan District, Taoyuan, TWN
HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.

HeXun Biosciences Co Headlines

No Headlines